Autoimmunity plays role in development of COPD, study finds

August 16, 2018 by Latina Emerson, Georgia State University
Micrograph showing emphysema (left – large empty spaces) and lung tissue with relative preservation of the alveoli (right). Credit: Wikipedia

Autoimmunity plays a role in the development of chronic obstructive pulmonary disease (COPD), according to a study led by Georgia State University and Vanderbilt University Medical Center that analyzed human genome information stored in Vanderbilt's DNA biobank.

COPD is a group of diseases that cause airflow blockage and breathing-related problems. COPD, which includes emphysema and chronic bronchitis, is the third leading cause of death in the United States and has been diagnosed in more than 13 million people, with millions more probably affected. There is no treatment for COPD.

Genome-wide association studies have already identified several genes that contribute to the development of COPD, but scientists still lack a complete understanding of the pathogenesis of this . In this study, the researchers examined the link between genetic variants in COPD and clinical phenotypes, or physical characteristics such as disease history, to understand the biological mechanisms underlying COPD.

Using genetic data from patients who participated in BioVU, Vanderbilt's DNA biobank that is linked to deidentified electronic health records, the researchers performed a phenome-wide association study (PheWAS) of 16 previously reported COPD-associated single nucleotide polymorphisms (SNPs) that were identified from a genome-wide association study. SNPs represent a difference in a single DNA building block, called a nucleotide, and are the most common type of genetic variation among people.

Data were available from 18,335 adults of European descent who had provided informed consent. The researchers identified 1,805 COPD cases. They defined phenotypes by using ICD-9 codes, or unique codes for different symptoms of disease.

"Because there's no treatment right now for COPD, we're trying to figure out whether we can diagnose or prognose this disease earlier to prevent it," said Dr. Xiangming Ji, assistant professor in the Byrdine F. Lewis College of Nursing and Health Professions at Georgia State. "People are genetically very similar, but a major difference is because of this (SNP). This could be changed by the environment also. So some people with a specific SNP are more prone to get this disease. We found that a specific SNP, rs2074488, is positively associated with COPD and is linked to the HLA-C gene, which presents a protein to B or T immune cells to kill bacteria or viruses. This makes COPD similar to autoimmune disease.

"This SNP is also associated with several , like type 1 diabetes and rheumatoid arthritis, which suggests a genetic link between autoimmune disease and COPD. Many years ago, people believed that one of the causes of COPD is because the autoimmune system attacks its own lungs. We kind of confirmed that by our big data."

The findings are published in the American Journal of Respiratory Cell and Molecular Biology.

This study could provide insight on opportunities for drug repurposing, Ji said. For instance, a drug that is effective for diabetes could possibly be used to treat COPD because both diseases involve autoimmune responses.

The findings suggest future studies should explore the role of the immune system in the pathogenesis of COPD. The researchers also hope that scientists will investigate how normal SNPs, such as those associated with metabolism pathways or different nutrient receptors, are related to COPD.

Explore further: Rheumatoid arthritis linked to an increased risk of COPD

More information: Xiangming Ji et al, A Phenome-Wide Association Study Uncovers a Role for Autoimmunity in the Development of Chronic Obstructive Pulmonary Disease, American Journal of Respiratory Cell and Molecular Biology (2018). DOI: 10.1165/rcmb.2017-0409LE

Related Stories

Rheumatoid arthritis linked to an increased risk of COPD

October 19, 2017
New research suggests that rheumatoid arthritis may increase the risk of developing chronic obstructive pulmonary disease (COPD). The findings, which appear in Arthritis Care & Research, indicate that greater vigilance may ...

Using lung function tests to diagnose COPD can help patients and reduce health care costs

November 14, 2016
Patients with chronic obstructive pulmonary disease (COPD) would benefit if pulmonary function testing was used more consistently to diagnose the condition, according to a study in CMAJ (Canadian Medical Association Journal)

Hospital quality linked to readmission rates for COPD and other diseases

March 21, 2017
Nearly one in five patients admitted to hospitals in the United States are readmitted within 30 days, at a cost of $17 billion annually. To reduce readmission rates, the federal Centers for Medicare & Medicaid Services (CMS) ...

College education and moderate alcohol intake linked to lower COPD risk

October 22, 2012
College education and alcohol consumption may be linked to risk for chronic obstructive pulmonary disease (COPD). Researchers from Kaiser Permanente Medical Group in Oakland, California, followed 126,019 people who supplied ...

Early COPD diagnosis could save billions

May 17, 2017
If 600,000 Swedish patients with chronic obstructive pulmonary disease (COPD) had received their diagnoses two years earlier, it could have saved more than SEK 15 billion in direct healthcare costs during the first two years ...

5-question survey may increase COPD diagnoses

October 22, 2012
A simple, five-question patient-administered survey (COPD-PS) may lead to increased diagnoses of chronic obstructive pulmonary disease (COPD).

Recommended for you

A new approach to developing a vaccine against vivax malaria

September 21, 2018
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...

Pre-clinical success for a universal flu vaccine offers hope for third generation approach

September 21, 2018
Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Communications.

Researchers define possible molecular pathway for neurodegeneration in prion diseases

September 21, 2018
A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.

Fighting a deadly parasite: Scientists devise a method to store Cryptosporidium, aiding vaccine research efforts

September 21, 2018
In May, just before one of the hottest summers on record, the U.S. Centers for Disease Control and Prevention issued a warning about diseases lurking in recreational water facilities like swimming pools and water playgrounds. ...

Scientists make significant discovery in the fight against drug-resistant tuberculosis

September 20, 2018
A team of scientists have identified a naturally occurring antibiotic that may help in the fight against drug-resistant Tuberculosis.

Anti-cancer drugs may hold key to overcoming antimalarial drug resistance

September 20, 2018
Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.